Zobrazeno 1 - 6
of 6
pro vyhledávání: '"McGregor PM 3rd"'
Autor:
Verner EL; Personal Genome Diagnostics (PGDx), Baltimore, Maryland. Electronic address: everner@pgdx.com., Jackson JB; Personal Genome Diagnostics (PGDx), Baltimore, Maryland. Electronic address: jjackson@pgdx.com., Severson E; Enterprise Oncology, Labcorp, Durham, North Carolina., Valkenburg KC; Personal Genome Diagnostics (PGDx), Baltimore, Maryland., Greer AE; Personal Genome Diagnostics (PGDx), Baltimore, Maryland., Riley DR; Personal Genome Diagnostics (PGDx), Baltimore, Maryland., Sausen M; Personal Genome Diagnostics (PGDx), Baltimore, Maryland., Maddox C; Personal Genome Diagnostics (PGDx), Baltimore, Maryland., McGregor PM 3rd; Personal Genome Diagnostics (PGDx), Baltimore, Maryland., Karandikar A; Personal Genome Diagnostics (PGDx), Baltimore, Maryland., Hastings SB; Enterprise Oncology, Labcorp, Durham, North Carolina., Previs RA; Enterprise Oncology, Labcorp, Durham, North Carolina., Reddy VP; Enterprise Oncology, Labcorp, Durham, North Carolina., Jensen TJ; Enterprise Oncology, Labcorp, Durham, North Carolina., Ramkissoon SH; Enterprise Oncology, Labcorp, Durham, North Carolina.
Publikováno v:
The Journal of molecular diagnostics : JMD [J Mol Diagn] 2023 Jul; Vol. 25 (7), pp. 477-489. Date of Electronic Publication: 2023 Apr 15.
Autor:
Keefer LA; Personal Genome Diagnostics Inc., Baltimore, MD, 21224, USA., White JR; Personal Genome Diagnostics Inc., Baltimore, MD, 21224, USA., Wood DE; Personal Genome Diagnostics Inc., Baltimore, MD, 21224, USA., Gerding KMR; Personal Genome Diagnostics Inc., Baltimore, MD, 21224, USA., Valkenburg KC; Personal Genome Diagnostics Inc., Baltimore, MD, 21224, USA., Riley D; Personal Genome Diagnostics Inc., Baltimore, MD, 21224, USA., Gault C; Personal Genome Diagnostics Inc., Baltimore, MD, 21224, USA., Papp E; Personal Genome Diagnostics Inc., Baltimore, MD, 21224, USA., Vollmer CM; Personal Genome Diagnostics Inc., Baltimore, MD, 21224, USA., Greer A; Personal Genome Diagnostics Inc., Baltimore, MD, 21224, USA., Hernandez J; Personal Genome Diagnostics Inc., Baltimore, MD, 21224, USA., McGregor PM 3rd; Personal Genome Diagnostics Inc., Baltimore, MD, 21224, USA., Zingone A; Laboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, Bethesda, MD, 20850, USA., Ryan BM; Laboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, Bethesda, MD, 20850, USA., Deak K; Department of Pathology, Duke University School of Medicine, Durham, NC, 27710, USA., McCall SJ; Department of Pathology, Duke University School of Medicine, Durham, NC, 27710, USA., Datto MB; Department of Pathology, Duke University School of Medicine, Durham, NC, 27710, USA., Prescott JL; PathGroup, Nashville, TN, 37217, USA., Thompson JF; Personal Genome Diagnostics Inc., Baltimore, MD, 21224, USA., Cerqueira GC; Personal Genome Diagnostics Inc., Baltimore, MD, 21224, USA., Jones S; Personal Genome Diagnostics Inc., Baltimore, MD, 21224, USA., Simmons JK; Personal Genome Diagnostics Inc., Baltimore, MD, 21224, USA., McElhinny A; Personal Genome Diagnostics Inc., Baltimore, MD, 21224, USA., Dickey J; Personal Genome Diagnostics Inc., Baltimore, MD, 21224, USA., Angiuoli SV; Personal Genome Diagnostics Inc., Baltimore, MD, 21224, USA., Diaz LA Jr; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA., Velculescu VE; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, 21287, USA., Sausen M; Personal Genome Diagnostics Inc., Baltimore, MD, 21224, USA. msausen@pgdx.com.
Publikováno v:
Nature communications [Nat Commun] 2022 May 20; Vol. 13 (1), pp. 2830. Date of Electronic Publication: 2022 May 20.
Autor:
Tricoli JV; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland., Boardman LA; Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota., Patidar R; Center for Cancer Research, National Cancer Institute, Bethesda, Maryland., Sindiri S; Center for Cancer Research, National Cancer Institute, Bethesda, Maryland., Jang JS; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota., Walsh WD; Molecular Characterization and Assay Development Laboratory, Leidos, Frederick, Maryland., McGregor PM 3rd; Molecular Characterization and Assay Development Laboratory, Leidos, Frederick, Maryland., Camalier CE; Molecular Characterization and Assay Development Laboratory, Leidos, Frederick, Maryland., Mehaffey MG; Molecular Characterization and Assay Development Laboratory, Leidos, Frederick, Maryland., Furman WL; Department of Hematology/Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee., Bahrami A; Department of Pathology, St. Jude Children's Research Hospital, Memphis, Tennessee., Williams PM; Molecular Characterization and Assay Development Laboratory, Leidos, Frederick, Maryland., Lih CJ; Molecular Characterization and Assay Development Laboratory, Leidos, Frederick, Maryland., Conley BA; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland., Khan J; Center for Cancer Research, National Cancer Institute, Bethesda, Maryland.
Publikováno v:
Cancer [Cancer] 2018 Mar 01; Vol. 124 (5), pp. 1070-1082. Date of Electronic Publication: 2017 Nov 30.
Autor:
Sims DJ; Molecular Characterization and Clinical Assay Development Laboratory, Frederick National Laboratory for Cancer Research, Frederick, Maryland., Harrington RD; Molecular Characterization and Clinical Assay Development Laboratory, Frederick National Laboratory for Cancer Research, Frederick, Maryland., Polley EC; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland., Forbes TD; Molecular Characterization and Clinical Assay Development Laboratory, Frederick National Laboratory for Cancer Research, Frederick, Maryland., Mehaffey MG; Molecular Characterization and Clinical Assay Development Laboratory, Frederick National Laboratory for Cancer Research, Frederick, Maryland., McGregor PM 3rd; Molecular Characterization and Clinical Assay Development Laboratory, Frederick National Laboratory for Cancer Research, Frederick, Maryland., Camalier CE; Molecular Characterization and Clinical Assay Development Laboratory, Frederick National Laboratory for Cancer Research, Frederick, Maryland., Harper KN; Molecular Characterization and Clinical Assay Development Laboratory, Frederick National Laboratory for Cancer Research, Frederick, Maryland., Bouk CH; Molecular Characterization and Clinical Assay Development Laboratory, Frederick National Laboratory for Cancer Research, Frederick, Maryland., Das B; Molecular Characterization and Clinical Assay Development Laboratory, Frederick National Laboratory for Cancer Research, Frederick, Maryland., Conley BA; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland., Doroshow JH; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland., Williams PM; Molecular Characterization and Clinical Assay Development Laboratory, Frederick National Laboratory for Cancer Research, Frederick, Maryland., Lih CJ; Molecular Characterization and Clinical Assay Development Laboratory, Frederick National Laboratory for Cancer Research, Frederick, Maryland. Electronic address: jason.lih@nih.gov.
Publikováno v:
The Journal of molecular diagnostics : JMD [J Mol Diagn] 2016 May; Vol. 18 (3), pp. 336-349.
Autor:
Chang LC; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA., Das B; Molecular Characterization and Clinical Assay Development Laboratory, Leidos Biomedical Research Inc., Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Lih CJ; Molecular Characterization and Clinical Assay Development Laboratory, Leidos Biomedical Research Inc., Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Si H; Molecular Characterization and Clinical Assay Development Laboratory, Leidos Biomedical Research Inc., Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Camalier CE; Molecular Characterization and Clinical Assay Development Laboratory, Leidos Biomedical Research Inc., Frederick National Laboratory for Cancer Research, Frederick, MD, USA., McGregor PM 3rd; Molecular Characterization and Clinical Assay Development Laboratory, Leidos Biomedical Research Inc., Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Polley E; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA.
Publikováno v:
Cancer informatics [Cancer Inform] 2016 Apr 27; Vol. 15, pp. 65-71. Date of Electronic Publication: 2016 Apr 27 (Print Publication: 2016).
Autor:
Kummar S; National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Oza AM; Princess Margaret Hospital, University of Toronto, Ontario, Canada., Fleming GF; The University of Chicago Medical Center, Chicago, Illinois., Sullivan DM; H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida., Gandara DR; University of California Davis Cancer Center, Davis, California., Naughton MJ; Washington University School of Medicine, St. Louis, Missouri., Villalona-Calero MA; The Ohio State University Comprehensive Cancer Center, James Cancer Hospital and Solove Research Institute, Columbus, Ohio., Morgan RJ Jr; City of Hope Comprehensive Cancer Center, Duarte, California., Szabo PM; National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Youn A; National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Chen AP; National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Ji J; Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland., Allen DE; National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Lih CJ; Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland., Mehaffey MG; Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland., Walsh WD; Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland., McGregor PM 3rd; Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland., Steinberg SM; National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Williams PM; Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland., Kinders RJ; Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland., Conley BA; National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Simon RM; National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Doroshow JH; National Cancer Institute, National Institutes of Health, Bethesda, Maryland. doroshoj@mail.nih.gov.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2015 Apr 01; Vol. 21 (7), pp. 1574-82. Date of Electronic Publication: 2015 Jan 14.